| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥4.2B | ¥4.4B | -5.7% |
| Operating Income | ¥-0.2B | ¥0.3B | -34.3% |
| Ordinary Income | ¥-0.7B | ¥-0.2B | -204.3% |
| Net Income | ¥1.6B | ¥0.2B | +924.3% |
| ROE | 12.8% | 1.4% | - |
FY2026 Q1 results: Revenue 4.2B yen (YoY -5.7%), Operating Income -0.2B yen (prior year +0.3B yen), Ordinary Income -0.7B yen (YoY -204.3%), Net Income 1.6B yen (YoY +924.3%). The company experienced a reversal to operating loss territory despite maintaining a gross margin of 33.2%, as SG&A expenses of 1.6B yen exceeded gross profit of 1.4B yen. The substantial net income increase was driven by extraordinary income of 2.3B yen from equity change gains, masking underlying operational weakness. Basic EPS surged to 22.06 yen from 2.86 yen, reflecting the one-time gain contribution rather than operational improvement.
Revenue declined 5.7% YoY to 4.2B yen, with the Financial Solution segment contracting 9.8% to 3.2B yen while Business Solution grew 9.0% to 0.6B yen and Healthcare expanded 16.2% to 0.4B yen. The core Financial Solution segment, representing 77.1% of total revenue, faced headwinds that offset growth in smaller segments. Cost of sales decreased to 2.8B yen, maintaining a gross profit margin of 33.2%, indicating stable pricing power and service delivery efficiency. However, SG&A expenses of 1.6B yen consumed 38.5% of revenue, exceeding gross profit and driving the operating loss of 0.2B yen compared to prior year operating income of 0.3B yen. This represents a 34.3% decline in operating performance. The operating margin deteriorated from +6.0% to -5.1%, a decline of 11.1 percentage points, primarily attributable to insufficient cost structure adjustment relative to revenue contraction. Non-operating expenses of 0.5B yen widened the ordinary loss to 0.7B yen. The extraordinary income of 2.3B yen from gain on change in equity transformed the pre-tax result to a profit of 1.6B yen. With minimal income tax expense of 0.0B yen and non-controlling interest deduction of 0.1B yen, net income reached 1.6B yen. This represents a revenue down/profit up pattern, though the profit increase is entirely attributable to non-recurring extraordinary gains rather than operational improvement.
Financial Solution segment generated revenue of 3.2B yen with operating income of 0.8B yen at a 24.0% margin, representing the core business with 77.1% revenue share. Despite a 9.8% revenue decline YoY from 3.5B yen, this segment maintained profitability with margin compression from 37.5% in the prior year. Business Solution segment posted revenue of 0.6B yen with operating loss of 0.1B yen at a -9.3% margin, improving from -27.1% margin in the prior year despite a modest revenue increase of 9.0%. Healthcare segment recorded revenue of 0.4B yen with operating loss of 0.1B yen at a -22.1% margin, showing improvement from -35.0% margin YoY alongside 16.2% revenue growth. The Financial Solution segment remains the profit engine, though its margin declined significantly. The two smaller segments continue to operate at losses, though loss rates are narrowing. Corporate costs not allocated to segments totaled 0.9B yen, representing overhead that compressed overall group operating margin into negative territory.
[Profitability] ROE 12.8% appears elevated but is driven by extraordinary gains rather than operational earnings; operating margin deteriorated to -5.1% from +6.0% YoY, a decline of 11.1 percentage points. Gross profit margin held steady at 33.2%, indicating stable unit economics, but SG&A ratio expanded to 38.5% from 34.9% YoY. Net profit margin of 38.1% is artificially elevated by extraordinary income and does not reflect sustainable profitability. [Cash Quality] Cash and deposits 7.5B yen provide 7.51x coverage of short-term debt of 1.0B yen, indicating strong liquidity. Cash to short-term liabilities ratio stands at 2.48x, reflecting ample near-term payment capacity. [Investment Efficiency] Asset turnover 0.255x remains low, below the industry median of 0.18x, reflecting moderate asset utilization. Investment securities increased 2.6B yen YoY to 4.5B yen, representing 27.4% of total assets and indicating strategic portfolio repositioning with associated mark-to-market risk. [Financial Health] Equity ratio 75.8% exceeds the industry median of 68.9%, demonstrating strong capitalization. Current ratio 338.7% and quick ratio 335.0% indicate robust short-term solvency. Debt-to-equity ratio 0.14x and debt-to-capital 12.5% reflect conservative leverage. Long-term loans of 0.8B yen represent manageable obligations. Accumulated deficit of -11.5B yen persists in retained earnings, though total equity base of 12.3B yen remains solid.
Cash and deposits increased 0.4B yen YoY to 7.5B yen despite operating loss generation, indicating continued balance sheet strength. Trade receivables declined 0.9B yen YoY to 1.7B yen, representing a 34.3% reduction that suggests improved collection efficiency or changes in revenue composition coinciding with the revenue decline. Inventories remained stable at 0.1B yen with minimal quarterly change. Investment securities expanded significantly by 2.6B yen to 4.5B yen, reflecting strategic capital deployment toward securities holdings that now comprise 27.4% of total assets, up from 12.4% in the prior year. Trade payables of 0.6B yen remained relatively stable. Long-term loans of 0.8B yen provide structural financing while short-term debt of 1.0B yen is well-covered by cash reserves at 7.51x. The balance sheet demonstrates continued liquidity strength with cash coverage of short-term liabilities at 2.48x, though the operating loss indicates that cash generation from core business requires improvement.
Ordinary income of -0.7B yen versus operating income of -0.2B yen shows non-operating net loss of approximately 0.5B yen, driven primarily by non-operating expenses. Non-operating income represents a minimal contribution to revenue at 0.0B yen. The substantial divergence between net income of 1.6B yen and operating loss of 0.2B yen is entirely explained by extraordinary income of 2.3B yen from gain on change in equity. This extraordinary item represents 555% of revenue and 146% of net income, underscoring that reported profitability is not reflective of recurring operational performance. The gain on equity change is a one-time event lacking sustainability. With operating income in loss territory, the company's core business failed to generate positive earnings before non-operating and extraordinary items. The absence of cash flow statement data for the quarter limits assessment of cash earnings quality, though the operating loss suggests negative operating cash generation. Earnings quality is therefore assessed as low, as net income is driven entirely by non-recurring gains rather than operational cash generation.
Full-year guidance projects revenue of 21.0B yen (YoY +14.3%), operating income of 1.0B yen, ordinary income of 0.1B yen, and net income of 2.4B yen. Q1 progress rates are revenue 19.8% (below standard 25%), operating income -21.8% (significantly below standard), ordinary income -715.4% (substantially negative), indicating challenging progress against full-year targets. The operating income shortfall is particularly pronounced, with Q1 posting a loss versus a full-year profit target. Revenue progress of 19.8% suggests need for acceleration in subsequent quarters to achieve the 21.0B yen full-year target. To reach operating income guidance of 1.0B yen, the remaining three quarters must collectively generate 1.2B yen, requiring significant operational turnaround from the Q1 loss position. The forecast assumes no revision this quarter. The company's forecast notes indicate that projections are based on currently available information and reasonable assumptions, with actual results subject to substantial variation. Given the Q1 operating loss and weak progress rates, achieving full-year operating income guidance will require substantial improvement in segment profitability, particularly in Financial Solution, and strict SG&A cost control. Net income guidance of 2.4B yen assumes no further extraordinary gains of the magnitude seen in Q1, implying that ordinary profitability must materialize for target achievement.
The company maintains a zero dividend policy with no interim or year-end dividend for the current fiscal year. The dividend forecast of 0.00 yen reflects continuation of this policy. With no dividend payments, the payout ratio is not applicable. No share buyback activity was disclosed for the quarter. Given the operating loss position and reliance on extraordinary gains for net income, dividend sustainability is absent in the current financial profile. Total return to shareholders is zero in the absence of both dividends and buybacks. Resumption of shareholder returns would require restoration of consistent operating profitability and sustained positive operating cash flow generation.
Operating profitability deterioration with SG&A expenses exceeding gross profit, resulting in -5.1% operating margin compared to +6.0% in the prior year, indicating structural cost challenges relative to revenue base. With SG&A at 38.5% of revenue versus gross margin of 33.2%, the company operates with negative operating leverage requiring either revenue growth or cost reduction to restore profitability. Financial Solution segment margin compression from 37.5% to 24.0% despite its core business status represents 13.5 percentage points of margin erosion that threatens overall profitability. Dependence on extraordinary gains for net income profitability, with Q1 net income of 1.6B yen entirely attributable to 2.3B yen gain on equity change, creates earnings volatility risk and lack of sustainable profit generation. Negative EBIT results in severely adverse interest coverage metrics with interest coverage ratio of -28.07x, indicating inability of operating earnings to service debt costs despite low absolute debt levels. Investment securities valuation risk with holdings of 4.5B yen representing 27.4% of total assets and up 70.7% YoY, exposing the balance sheet to market value fluctuations and potential impairment if valuations decline. Working capital efficiency challenges evidenced by DSO of 151 days and CCC of 122 days, indicating extended cash conversion cycles that tie up capital, despite recent improvements in receivables collection.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: ROE 12.8% substantially exceeds the IT/Telecom industry median of 0.2% (IQR: 0.1%-2.3%), though this outperformance is driven by extraordinary gains rather than operational strength. Operating margin of -5.1% falls below the industry median of 5.3% (IQR: 3.0%-26.3%), ranking in the bottom quartile and indicating operational underperformance. Net profit margin of 38.2% significantly exceeds the industry median of 0.6% (IQR: 0.5%-16.6%), but this comparison is distorted by non-recurring extraordinary income.
Efficiency: Asset turnover of 0.255x exceeds the industry median of 0.18x (IQR: 0.15-0.19), indicating relatively stronger asset utilization despite operational challenges. Revenue growth of -5.7% contrasts unfavorably with the industry median growth of 25.5% (IQR: 20.9%-26.2%), placing the company in a declining trajectory relative to expanding industry peers.
Financial Health: Equity ratio of 75.8% exceeds the industry median of 68.9% (IQR: 64.1%-79.9%), reflecting above-median capitalization strength. Financial leverage of 1.32x is below the industry median of 1.45x (IQR: 1.28-1.49), indicating conservative capital structure.
Returns: ROA of 3.3% exceeds the industry median of 0.1% (IQR: 0.1%-2.0%), though again this reflects extraordinary gain distortion. ROIC positioning relative to industry median of 0.01 (IQR: 0.01-0.59) cannot be meaningfully assessed given operational losses.
(Industry: IT/Telecom, N=3 companies, Comparison: 2025-Q1 period, Source: Proprietary analysis)
Operating profitability remains structurally challenged with Q1 posting an operating loss as SG&A expenses exceeded gross profit, marking a deterioration from prior year operating income and highlighting urgent need for cost structure realignment or revenue recovery to restore positive operating margins. Net income expansion to 1.6B yen is entirely attributable to extraordinary gain on equity change of 2.3B yen, creating a non-sustainable earnings profile that masks underlying operational weakness and dependence on non-recurring items for reported profitability. Financial position demonstrates resilience with equity ratio of 75.8%, cash holdings of 7.5B yen providing 7.51x coverage of short-term debt, and conservative debt-to-capital of 12.5%, though the deployment of capital into investment securities totaling 4.5B yen introduces mark-to-market risk and questions regarding strategic allocation priorities. Segment dynamics show core Financial Solution business experiencing both revenue contraction of 9.8% and margin compression from 37.5% to 24.0%, while loss-making Business Solution and Healthcare segments show revenue growth and narrowing losses, suggesting a portfolio transition phase requiring monitoring of whether growth segments can achieve profitability and offset core segment pressure. Full-year guidance achievement faces significant execution risk with Q1 progress rates of 19.8% on revenue and negative on operating income, requiring substantial sequential improvement in remaining quarters to reach operating income target of 1.0B yen, particularly given the absence of extraordinary gains of similar magnitude to support results.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.